title: The extended pharmaceutical enterprise.
abstract: The availability of widespread contractual services led to the birth of the virtual company in the 1990s. As the concept has matured, and the biotechnology sector diversified, interchange of intellectual property in the form of collaborative and license arrangements opens up still further the opportunities for outsourced forms of pharmaceutical R&D.
authors.affiliation: Arachnova, St John's Innovation Centre, Cambridge, UK CB4 0WS. david.cavalla@arachnova.com
authors.forename: David
authors.initials: D
authors.lastname: Cavalla
mesh_terms: D032982:Contracts; D004345:Drug Industry / Q000458:organization & administration* / Q000639:trends; D018973:Intellectual Property; D008004:Licensure; D040541:Marketing / Q000458:organization & administration; D020416:Outsourced Services / Q000191:economics; D012106:Research / Q000458:organization & administration; D018581:Technology Transfer